By Gina Shaw
More than 92% of patients tested by the clinical pharmacogenomics service at Boston Children’s Hospital (BCH) receive an actionable result, said Shannon Manzi, PharmD, BCCPS, the director of the service, during a session on pharmacogenomic testing in children at the ASHP 2021 Midyear Clinical Meeting and Exposition, held virtually.
DECEMBER 14, 2021